NRXP•benzinga•
Ascendiant Capital Maintains Buy on NRX Pharmaceuticals, Raises Price Target to $46
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 29, 2025 by benzinga